Cumulative incidence of relapse and NRM after allogeneic HSCT. The cumulative incidence of relapse was 20% (95% CI, 9% to 35%) at day 100 and 26% (95% CI, 13% to 42%) at 1 year and 3 years, respectively. The cumulative incidence of NRM was 3% (95% CI, 0.2% to 13%) at day 100 and 6% (95% CI, 1% to 17%) at 1 year, respectively.